Drug Shortage Report for MAR-METHIMAZOLE
| Report ID | 176433 |
| Drug Identification Number | 02480107 |
| Brand name | MAR-METHIMAZOLE |
| Common or Proper name | MAR-Methimazole |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHIMAZOLE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | H03BB |
| ATC description | ANTITHYROID PREPARATIONS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2022-12-02 |
| Estimated end date | 2023-02-15 |
| Actual end date | 2022-01-05 |
| Shortage status | Avoided shortage |
| Updated date | 2023-01-05 |
| Company comments | Shortage Resolved |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2023-01-05 | French | Compare |
| v10 | 2023-01-05 | English | Compare |
| v9 | 2022-12-03 | English | Compare |
| v8 | 2022-12-02 | French | Compare |
| v7 | 2022-12-02 | English | Compare |
| v6 | 2022-12-02 | French | Compare |
| v5 | 2022-12-02 | English | Compare |
| v4 | 2022-12-02 | English | Compare |
| v3 | 2022-12-01 | French | Compare |
| v2 | 2022-12-01 | English | Compare |
| v1 | 2022-12-01 | English | Compare |
Showing 1 to 11 of 11